Breaking News

Ampersand Capital Partners Acquires Full-Service Manufacturer Biologos

Plans to make investments to expand Biologos' capabilities, product offerings, and geographic reach.

Author Image

By: Charlie Sternberg

Associate Editor

Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, has acquired Biologos LLC, a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera.   Founded in 1976, Biologos provides custom and standard products spanning cell culture media, reagents, enzymes, salts/buffers, and sera, many with customized container, fill, and packaging solutions. Biologos operates from ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters